NCT01132625View on ClinicalTrials.gov

Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

AUY922

Trial Locations (2)

277-8577

Novartis Investigative Site, Kashiwa

411-8777

Novartis Investigative Site, Sunto-gun

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY